Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 2
1998 4
1999 1
2000 2
2001 1
2002 1
2003 3
2004 3
2005 3
2006 6
2007 3
2008 22
2009 40
2010 36
2011 60
2012 96
2013 110
2014 183
2015 145
2016 129
2017 108
2018 95
2019 92
2020 79
2021 103
2022 75
2023 77
2024 55

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,319 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study.
Giaccone G, Kim C, Thompson J, McGuire C, Kallakury B, Chahine JJ, Manning M, Mogg R, Blumenschein WM, Tan MT, Subramaniam DS, Liu SV, Kaplan IM, McCutcheon JN. Giaccone G, et al. Lancet Oncol. 2018 Mar;19(3):347-355. doi: 10.1016/S1470-2045(18)30062-7. Epub 2018 Jan 26. Lancet Oncol. 2018. PMID: 29395863 Free PMC article. Clinical Trial.
LC-MS-based metabolomics.
Zhou B, Xiao JF, Tuli L, Ressom HW. Zhou B, et al. Mol Biosyst. 2012 Feb;8(2):470-81. doi: 10.1039/c1mb05350g. Epub 2011 Nov 1. Mol Biosyst. 2012. PMID: 22041788 Free PMC article. Review.
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study.
Swain SM, Kim SB, Cortés J, Ro J, Semiglazov V, Campone M, Ciruelos E, Ferrero JM, Schneeweiss A, Knott A, Clark E, Ross G, Benyunes MC, Baselga J. Swain SM, et al. Lancet Oncol. 2013 May;14(6):461-71. doi: 10.1016/S1470-2045(13)70130-X. Epub 2013 Apr 18. Lancet Oncol. 2013. PMID: 23602601 Free PMC article. Clinical Trial.
Cadherin 11 Promotes Immunosuppression and Extracellular Matrix Deposition to Support Growth of Pancreatic Tumors and Resistance to Gemcitabine in Mice.
Peran I, Dakshanamurthy S, McCoy MD, Mavropoulos A, Allo B, Sebastian A, Hum NR, Sprague SC, Martin KA, Pishvaian MJ, Vietsch EE, Wellstein A, Atkins MB, Weiner LM, Quong AA, Loots GG, Yoo SS, Assefnia S, Byers SW. Peran I, et al. Gastroenterology. 2021 Mar;160(4):1359-1372.e13. doi: 10.1053/j.gastro.2020.11.044. Epub 2020 Dec 9. Gastroenterology. 2021. PMID: 33307028 Free PMC article.
Cohesin mutations in human cancer.
Hill VK, Kim JS, Waldman T. Hill VK, et al. Biochim Biophys Acta. 2016 Aug;1866(1):1-11. doi: 10.1016/j.bbcan.2016.05.002. Epub 2016 May 17. Biochim Biophys Acta. 2016. PMID: 27207471 Free PMC article. Review.
Demystifying the O-GlcNAc Code: A Systems View.
Ma J, Hou C, Wu C. Ma J, et al. Chem Rev. 2022 Oct 26;122(20):15822-15864. doi: 10.1021/acs.chemrev.1c01006. Epub 2022 Mar 18. Chem Rev. 2022. PMID: 35302357 Review.
Emerging themes in cohesin cancer biology.
Waldman T. Waldman T. Nat Rev Cancer. 2020 Sep;20(9):504-515. doi: 10.1038/s41568-020-0270-1. Epub 2020 Jun 8. Nat Rev Cancer. 2020. PMID: 32514055 Review.
1,319 results